21 CFR § 212.61 Current Good Manufacturing Practice for Positron Emission Tomography Drugs

§ 212.61 What must I do to ensure the stability of my PET drug products through expiry?

Current through Sep 8, 2026 · Read all of Part 212

(a) Stability testing program. You must establish, follow, and maintain a written testing program to assess the stability characteristics of your PET drug products. The test methods must be reliable, meaningful, and specific. The samples tested for stability must be representative of the lot or batch from which they were obtained and must be stored under suitable conditions.

(b) Storage conditions and expiration dates. The results of such stability testing must be documented and used in determining appropriate storage conditions and expiration dates and times for each PET drug product you produce.

← § 212.60 What requirements apply to the laboratories where I test components, in-process materials, and finished PET drug products?§ 212.70 What controls and acceptance criteria must I have for my finished PET drug products? →